NCT06942793View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

396

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

October 20, 2025

Study Completion Date

November 15, 2025

Conditions

Dry Eye Disease

Interventions

DRUG

CsA-PG Ophthalmic Gel

Administer to eyes

DRUG

CsA Ophthalmic Gel

Administer to eyes

All Listed Sponsors

lead

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

INDUSTRY